Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting
2024-04-09 19:00
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved pulsed field ablation system
2024-04-09 18:15
Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA
2024-04-09 17:52
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors
2024-04-09 14:00
Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial
2024-04-09 09:18
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib
2024-04-09 08:30
Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR
2024-04-09 04:53
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China
2024-04-08 22:00
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals
2024-04-08 21:00
Medit Unveils i900: The Next Evolution of Intraoral Scanners
2024-04-08 21:00
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
2024-04-08 20:00
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego
2024-04-08 20:00
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort
2024-04-08 17:19
D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline
2024-04-08 15:00
Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial
2024-04-08 08:47
Laekna Announces Two Poster Presentations on Internally Discovered Drug Candidates at AACR 2024
2024-04-08 08:30
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
2024-04-08 08:00
AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting
2024-04-08 07:58
IMPACT IN ACTION: Cure Brain Cancer Foundation Launches Inaugural 5-Year Guardian Trust Early Career Fellowship valued at $575,000
2024-04-08 07:00
FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment of Patients with advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
2024-04-07 19:09
1
77
78
79
80
81
962